|
Hypertensive Heartbreak
|
Emily S. Lau, M.D., Benjamin Scirica, M.D., M.P.H., Inga-Marie Schaefer, M.D., Amy L. Miller, M.D., Ph.D., et al. |
2021 |
N Engl J Med 2021; 384:2145-2152 |
Open
|
|
Total Hip and Total Knee Replacement List of authors.
|
William H. Harris, M.D., and Clement B. Sledge, M.D. |
1990 |
N Engl J Med 1990; 323:725-731 |
Open
|
|
Rivaroxaban versus Enoxaparin for Thromboprophylaxis after Hip Arthroplasty
|
Bengt I. Eriksson, M.D., Ph.D., Lars C. Borris, M.D., Richard J. Friedman, M.D., Sylvia Haas, M.D., et al., for the RECORD1 Study Group* |
2008 |
N Engl J Med 2008; 358:2765-2775 |
Open
|
|
Minimally Invasive Total Knee Arthroplasty for Osteoarthritis
|
Seth S. Leopold, M.D. |
2009 |
N Engl J Med 2009; 360:1749-1758 |
Open
|
|
Hybrid Strategy to Prevent Venous Thromboembolism after Joint Arthroplasty
|
David Garcia, M.D. |
2018 |
N Engl J Med 2018; 378:762-763 |
Open
|
|
Infection Associated with Prosthetic Joints
|
Jose L. Del Pozo, M.D., Ph.D., and Robin Patel, M.D. |
2009 |
N Engl J Med 2009; 361:787-794 |
Open
|
|
Factor XI Antisense Oligonucleotide for Prevention of Venous Thrombosis List of authors.
|
Harry R. Büller, M.D., Claudette Bethune, Ph.D., Sanjay Bhanot, M.D., Ph.D., David Gailani, M.D., et al., for the FXI-ASO TKA Investigators* |
2015 |
N Engl J Med 2015; 372:232-240 |
Open
|
|
Differences between Men and Women in the Rate of Use of Hip and Knee Arthroplasty
|
Gillian A. Hawker, M.D., James G. Wright, M.D., M.P.H., Peter C. Coyte, Ph.D., J. Ivan Williams, Ph.D., et al. |
2000 |
N Engl J Med 2000; 342:1016-1022 |
Open
|
|
Total Hip Arthroplasty or Hemiarthroplasty for Hip Fracture
|
|
2020 |
N Engl J Med 2020; 382:1072-1074 |
Open
|
|
Total Hip Arthroplasty or Hemiarthroplasty for Hip Fracture List of authors.
|
|
2019 |
N Engl J Med 2019; 381:2199-2208 |
Open
|
|
Predictors of Rehospitalization for Symptomatic Venous Thromboembolism after Total Hip Arthroplasty
|
Richard H. White, M.D., Sharmeen Gettner, Ph.D., Jeffrey M. Newman, M.D., M.P.H., Kenneth B. Trauner, M.D., et al. |
2000 |
N Engl J Med 2000; 343:1758-1764 |
Open
|
|
Racial, Ethnic, and Geographic Disparities in Rates of Knee Arthroplasty among Medicare Patients
|
Jonathan Skinner, Ph.D., James N. Weinstein, D.O., Scott M. Sporer, M.D., and John E. Wennberg, M.D., M.P.H. |
2003 |
N Engl J Med 2003; 349:1350-1359 |
Open
|
|
Racial, Ethnic, and Geographic Disparities in Rates of Knee Arthroplasty
|
|
2004 |
N Engl J Med 2004; 350:305-306 |
Open
|
|
Should Total Hip Arthroplasty Be Used for Hip Fracture?
|
Jan-Erik Gjertsen, M.D., Ph.D. |
2019 |
N Engl J Med 2019; 381:2261-2262 |
Open
|
|
Rivaroxaban versus Enoxaparin for Thromboprophylaxis after Total Knee Arthroplasty
|
Michael R. Lassen, M.D., Walter Ageno, M.D., Lars C. Borris, M.D., Jay R. Lieberman, M.D., et al. |
2008 |
N Engl J Med 2008; 358:2776-2786 |
Open
|
|
Hip Arthroplasty
|
John M. Cuckler, M.D. |
1992 |
N Engl J Med 1992; 326:777 |
Open
|
|
Aspirin or Rivaroxaban for VTE Prophylaxis after Hip or Knee Arthroplasty
|
David R. Anderson, M.D., Michael Dunbar, M.D., John Murnaghan, M.D., Susan R. Kahn, M.D., et al. |
2018 |
N Engl J Med 2018; 378:699-707 |
Open
|
|
Appropriateness Criteria and Elective Procedures — Total Joint Arthroplasty
|
Hassan M.K. Ghomrawi, Ph.D., M.P.H., Bruce R. Schackman, Ph.D., and Alvin I. Mushlin, M.D. |
2012 |
N Engl J Med 2012; 367:2467-2469 |
Open
|
|
Disparities in the Use of Total Joint Arthroplasty
|
Mary E. Charlson, M.D., and John P. Allegrante, Ph.D. |
2000 |
N Engl J Med 2000; 342:1044-1045 |
Open
|
|
Minimally Invasive Total Knee Arthroplasty
|
|
2009 |
N Engl J Med 2009; 361:633-634 |
Open
|
|
The Technique of Total Hip Arthroplasty
|
Thomas A. Einhorn, M.D. |
1993 |
N Engl J Med 1993; 328:591-592 |
Open
|
|
Venous Thromboembolism Prophylaxis after Hip or Knee Arthroplasty
|
|
2018 |
N Engl J Med 2018; 378:1848-1849 |
Open
|
|
Association of Medicare Mandatory Bundled Payment Reform With Joint Replacement Surgery Use for Beneficiaries With Alzheimer Disease and Related Dementias
|
Caroline P. Thirukumaran, MBBS, MHA, PhD1,2,3; Benjamin F. Ricciardi, MD1,3; Xueya Cai, PhD4; et al |
2022 |
JAMA Health Forum. 2022;3(2):e215111. |
Open
|
|
Occult Vitamin D Deficiency in Postmenopausal US Women With Acute Hip Fracture
|
Meryl S. LeBoff, MD; Lynn Kohlmeier, MD; Shelley Hurwitz, PhD; et al |
1999 |
JAMA. 1999;281(16):1505-1511. |
Open
|
|
Preoperative vs Postoperative Initiation of Low-Molecular-Weight Heparin Prophylaxis Against Venous Thromboembolism in Patients Undergoing Elective Hip Replacement
|
Russell D. Hull, MBBS, MSC; Rollin F. Brant, PhD; Graham F. Pineo, MD; et al |
1999 |
Arch Intern Med. 1999;159(2):137-141. |
Open
|
